Cargando…

Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study

To reach the goals of the Global Hepatitis Elimination 2030 program, Indonesia is now preparing a new regulation for hepatitis B vaccinations for adult population. This study aimed to determine the factors influencing vaccine uptake for hepatitis B in the adult population, and identify barriers to,...

Descripción completa

Detalles Bibliográficos
Autores principales: Machmud, Putri Bungsu, Führer, Amand, Gottschick, Cornelia, Mikolajczyk, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967628/
https://www.ncbi.nlm.nih.gov/pubmed/36851280
http://dx.doi.org/10.3390/vaccines11020398
_version_ 1784897312382779392
author Machmud, Putri Bungsu
Führer, Amand
Gottschick, Cornelia
Mikolajczyk, Rafael
author_facet Machmud, Putri Bungsu
Führer, Amand
Gottschick, Cornelia
Mikolajczyk, Rafael
author_sort Machmud, Putri Bungsu
collection PubMed
description To reach the goals of the Global Hepatitis Elimination 2030 program, Indonesia is now preparing a new regulation for hepatitis B vaccinations for adult population. This study aimed to determine the factors influencing vaccine uptake for hepatitis B in the adult population, and identify barriers to, and facilitators of, hepatitis B vaccination programmes. An explanatory sequential mixed methods design was implemented in this study. We conducted a survey involving 893 participants in the general population followed by 14 in-depth interviews with health providers. The survey found that only 15% (95% confidence interval 13–18%) of participants received at least one dose of the hepatitis B vaccine. Factors associated with vaccine uptake were, living in Yogyakarta compared to living in Aceh, having secondary and higher education compared to primary education, working as a health worker compared to working in other sectors, and having health insurance that covered hepatitis B vaccination compared to not having such health insurance. Our qualitative study also identified several barriers to the adult hepatitis B vaccination programme in Indonesia such as the high cost of vaccination, lack of vaccine availability in certain areas, limited human resources to implement the hepatitis B vaccination programme, and the ineffective dissemination of hepatitis B vaccination. This study highlights that accessibility and affordability of vaccinations are important determinants of vaccination uptake that should be taken into account when planning vaccination campaigns.
format Online
Article
Text
id pubmed-9967628
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99676282023-02-27 Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study Machmud, Putri Bungsu Führer, Amand Gottschick, Cornelia Mikolajczyk, Rafael Vaccines (Basel) Article To reach the goals of the Global Hepatitis Elimination 2030 program, Indonesia is now preparing a new regulation for hepatitis B vaccinations for adult population. This study aimed to determine the factors influencing vaccine uptake for hepatitis B in the adult population, and identify barriers to, and facilitators of, hepatitis B vaccination programmes. An explanatory sequential mixed methods design was implemented in this study. We conducted a survey involving 893 participants in the general population followed by 14 in-depth interviews with health providers. The survey found that only 15% (95% confidence interval 13–18%) of participants received at least one dose of the hepatitis B vaccine. Factors associated with vaccine uptake were, living in Yogyakarta compared to living in Aceh, having secondary and higher education compared to primary education, working as a health worker compared to working in other sectors, and having health insurance that covered hepatitis B vaccination compared to not having such health insurance. Our qualitative study also identified several barriers to the adult hepatitis B vaccination programme in Indonesia such as the high cost of vaccination, lack of vaccine availability in certain areas, limited human resources to implement the hepatitis B vaccination programme, and the ineffective dissemination of hepatitis B vaccination. This study highlights that accessibility and affordability of vaccinations are important determinants of vaccination uptake that should be taken into account when planning vaccination campaigns. MDPI 2023-02-09 /pmc/articles/PMC9967628/ /pubmed/36851280 http://dx.doi.org/10.3390/vaccines11020398 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Machmud, Putri Bungsu
Führer, Amand
Gottschick, Cornelia
Mikolajczyk, Rafael
Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study
title Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study
title_full Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study
title_fullStr Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study
title_full_unstemmed Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study
title_short Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study
title_sort barriers to and facilitators of hepatitis b vaccination among the adult population in indonesia: a mixed methods study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967628/
https://www.ncbi.nlm.nih.gov/pubmed/36851280
http://dx.doi.org/10.3390/vaccines11020398
work_keys_str_mv AT machmudputribungsu barrierstoandfacilitatorsofhepatitisbvaccinationamongtheadultpopulationinindonesiaamixedmethodsstudy
AT fuhreramand barrierstoandfacilitatorsofhepatitisbvaccinationamongtheadultpopulationinindonesiaamixedmethodsstudy
AT gottschickcornelia barrierstoandfacilitatorsofhepatitisbvaccinationamongtheadultpopulationinindonesiaamixedmethodsstudy
AT mikolajczykrafael barrierstoandfacilitatorsofhepatitisbvaccinationamongtheadultpopulationinindonesiaamixedmethodsstudy